Acepodia, Inc. (TPEX:6976)
Taiwan
· Delayed Price · Currency is TWD 12.65
-0.20 (-1.56%)
At close: Mar 9, 2026
Acepodia Market Cap
Acepodia has a market cap or net worth of 7.36 billion as of March 9, 2026. Its market cap has decreased by -34.01% in one year.
Market Cap
7.36B
Enterprise Value
2.52B
Revenue
301.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
12.65
Market Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 7.36B, a decrease of -67.88%. That is a compound annual growth rate of -35.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.48B | -16.30% |
| Dec 31, 2025 | 8.94B | -10.43% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adimmune | 7.67B |
| Mycenax Biotech | 6.77B |
| TaiGen Biopharmaceuticals Holdings | 8.68B |
| PharmaEngine | 8.78B |
| Savior Lifetec | 6.29B |
| Sinphar Pharmaceutical | 5.86B |
| Gongwin Biopharm Holdings | 9.81B |
| Steminent Biotherapeutics | 5.42B |